Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
FTO-IN-12
Cat. No.:
OB0425LY-312
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
FTO-IN-12 is a specific inhibitor of FTO (fatty acid demethylase O) that can affect the process of RNA methylation. FTO plays a key role in the regulation of body weight and metabolism.
Synonyms:
4-Amino-8-chloroquinoline-3-carboxylic acid; 955328-22-0; 3-Quinolinecarboxylic acid, 4-amino-8-chloro-
CAS No.:
955328-22-0
Compound CID:
17028176
Formula:
C10H7ClN2O2
Formula Weight:
222.63
Specification
Target:
Fat mass and obesity-associated protein (FTO)
Pathway:
Metabolic enzyme/Protease
Storage:
Storage at -20°C.
Applications:
FTO-IN-12 is widely used in biomedical research to study obesity, diabetes and other metabolic diseases.
